moderna featured image
News Pharmaceutical & Biotech Stories

Moderna to Supply up to 125M COVID-19 Vaccine Doses

Thursday, December 3, Moderna expects to have between 100 million and 125 million doses of its experimental vaccine available in the first quarter of 2021.

The company said 85 million to 100 million of those doses would be available in the United States, with 15 million to 25 million available outside the country.

Moderna said the first-quarter doses are within the 500 million to up to 1 billion doses the company expects to manufacture globally in 2021.

Results from an early-stage trial showed that the vaccine, mRNA-1273, produced high levels of binding and neutralizing antibodies that declined slightly over time but remained elevated in all participants three months after the booster vaccination.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS